Prathap Kumar Mahalingaiah, DVM, MS, PhD, DABT is an American Board certified Toxicologist (DABT) with 8+ years of experience in Preclinical Toxicology and Pathology. Prathap started his career in 2007 as a Toxico-pathologist in GLP Contract Research Organization (CRO) in India.
He is currently working as a Senior Scientist in the Investigative Toxicology and Pathology Department at Abbvie, North Chicago, USA. He is actively involved in designing and conducting in vitro and in vivo investigative toxicology studies to understand target independent uptake (non-specific) mediated toxicity of ADCs. He is also involved in conducting studies to identify early biomarkers for safety issues associated with novel Bio-therapeutics including ADCs.
Mahalingaiah completed his bachelor’s degree in Veterinary Medicine (DVM) and Masters in Veterinary Pathology from Veterinary College, Bangalore India. He received PhD degree in Toxicology from Texas Tech University, USA. For his PhD research, he investigated role of epigenetic changes in mediating chronic oxidative stress induced renal carcinogenesis.
He served as an elected officer for different specialty sections/special interest groups within Society of Toxicology (SOT) including Biotechnology Specialty Section (BTSS), Risk Assessment Specialty Section (RASS), Association of Scientists of Indian Origin (ASIO) and Graduate Student Advisory Council (GSLC). Prathap is also serving as an editorial member and ad hoc peer reviewer for several scientific journals. He has authored/co-authored 13 peer reviewed research papers and book chapters.